Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XinKang-I for Chronic Heart Failure
NCT05847959Not yet recruiting
- Sponsor
- Dongguan Traditional Chinese Medicine Hospital
- Start
- May 2023
- Primary completion
- Dec 2025
01
Overview
Randomised, single-blind trial in chronic heart failure (CHF), sponsored by Dongguan Traditional Chinese Medicine Hospital. Primary endpoints: 6-minute walking distance at 8 weeks, Oxygen consumption volume of anaerobic threshold at 8 weeks and 1 more. Planned start May 2023; status: not yet recruiting.
02
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT05847959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05847959.